Nachrichten zur Xenon Pharmaceuticals Aktie

Xenon (XENE) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DateMay 7, 2026Call participantsPresident and Chief Executive Officer — Ian MortimerChief Medical Officer — Christopher John…

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

…

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -58.33% and +4.22%, respectively, for the quarter ended December 2025. Do…

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused…

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

DEER PARK, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON),…

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today…

Xenon Pharmaceuticals Aktie: Rivale scheitert - Xenon profitiert?

St. Louis (www.aktiencheck.de) - Xenon Pharmaceuticals-Aktienanalyse von Stifel:Paul Matteis, Analyst von Stifel, habe das Rating "buy" für die Aktie von…

Xenon Pharmaceuticals Inc. (XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation Transcript

…

Why Is Xenon Pharmaceuticals (XENE) Up 9.7% Since Last Earnings Report?

Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Eton Pharma (ETON) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DATEThursday, November 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Sean BrynjelsenChief Financial Officer…

Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call Transcript

…

Algernon Pharmaceuticals Completes Name Change to Algernon Health

VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN)…

Xenon Pharmaceuticals Inc. (XENE) Nav1.7 And Kv7 Programs Investor Webinar Transcript

…

Algernon Announces Preferred Share Class Approved at Annual and Special Meeting

VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT:…

Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -900.00% and +13.24%, respectively, for the quarter ended June 2025. Do…

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused…

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?

Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT:…

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

…

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -22.22% and 6.71%, respectively, for the quarter ended March 2025. Do…

Xenon Pharmaceuticals Inc. (XENE) Q1 2025 Earnings Call Transcript

…

Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 48.2% in Xenon Pharmaceuticals (XENE).…

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Eton Pharmaceuticals (ETON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

…

Xenon Pharmaceuticals Inc. (XENE) Q4 2024 Earnings Call Transcript

…

Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalners Epilepsy Potential

…

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

VANCOUVER, British Columbia and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused…

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

DEER PARK, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON),…

Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call Transcript

…

Deep Track Capitals Strategic Investment in Reneo Pharmaceuticals

On October 4, 2024, Deep Track Capital, LP (Trades, Portfolio) marked a significant portfolio addition by acquiring 68,415.6 shares of…

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON),…

Earnings call: Xenon Pharmaceuticals Q2 2024 results and clinical updates By Investing.com

Earnings call: Xenon Pharmaceuticals Q2 2024 results and clinical updates…

Xenon Pharmaceuticals: Good Data In Epilepsy, But Doubts Remain

…

Xenon Pharmaceuticals, Inc. (XENE) Q2 2024 Earnings Call Transcript

…

Algernon Pharmaceuticals Announces Closing of Private Placement

VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the…

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

DEER PARK, Ill., July 30, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON),…

Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript

…

Xenon Pharmaceuticals Inc. (XENE) Q1 2024 Earnings Call Transcript

…

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON),…

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN)…

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced…

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Researchs Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT:…

dpa-AFX ProFeed